GIP/GLP-1 Receptor Agonist | Mounjaro Injection
Mounjaro Online Consultation
Weekly injection for appetite management. GIP / GLP-1 · Weight-loss use is off-label.
English phone consultation · 2.5 mg · 1 pen
Total: ¥8,000 (tax included)
Medicine ¥6,000 + handling ¥2,000 + consultation ¥0 with purchase + standard delivery ¥0 under the current shipping offer.
Refrigerated delivery within Japan. Prescription follows a medical assessment.
All doses, prices & fee conditionsOnce-weekly self-injection to support weight management
- Nationwide delivery, fully online flow (consultation → payment → shipping)
- Once-weekly self-injection (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg)
- Only genuine products via authorized distributors
For this self-pay weight-management service, the consultation fee and standard shipping fee are 0 JPY. A 2,000 JPY handling fee applies when ordering only one Mounjaro or Zepbound pen; it is waived when another medicine is included in the same order. Medicine costs are separate. If you choose not to purchase or decline the prescription after completing the consultation, a 3,000 JPY consultation fee applies. No consultation fee is charged if a medical assessment of the questionnaire means the consultation is not performed. See the relevant medicine page for current prices.
Book your consultation in English
- Use the WEB booking page to choose an available appointment. Make a separate reservation for each patient.
- For a first appointment, attach an image of your identification document, such as a passport, and complete the online medical questionnaire as instructed.
- Register a reachable phone number and let us know that you would like the consultation in English.
- The doctor assesses whether treatment or a prescription is appropriate. Payment follows the consultation.
The clinic calls the phone number you register. Consultations are available in English and Japanese. If you are visiting from overseas and cannot receive calls from a Japanese phone number, contact us in advance to arrange a LINE call as an alternative.
Contact official LINE if you need help completing the booking form. Use WEB booking for a medical appointment. Use official LINE for questions before a weight-management appointment or help with the booking process. A LINE message alone does not book a consultation.
[Doctor’s Overview] What is the GLP-1 injection “Mounjaro”?
Mounjaro (tirzepatide) is a dual agonist acting on both GLP-1 and GIP receptors. It supports appetite control and post-meal glucose regulation, enabling sustainable weight management with a once-weekly injection. Mounjaro is approved for type 2 diabetes in Japan; weight-management use is off-label. The same ingredient is marketed as Zepbound for obesity under specific approved conditions in Japan.
Engages GLP-1/GIP to naturally reduce intake and blunt glucose spikes.
The Japanese diabetes label starts at 2.5 mg weekly for 4 weeks, then 5 mg. If needed, the physician may increase by 2.5 mg at intervals of at least 4 weeks, up to 15 mg. Weight-management use is off-label.
Consultation & standard shipping are free. Refrigerated shipping free during campaign.
How Mounjaro (GLP-1/GIP) works
This medicine enhances your body’s natural regulation of eating. It aims for gentle, sustainable change—without extreme willpower.
- Strengthens the “I’m full” signal
- Reduces hedonic snacking urges
- Helps adjust portion sizes naturally
- Slows gastric emptying
- Fullness lasts longer after meals
- Helps curb “constant hunger”
- Blunts post-meal glucose spikes
- Supports insulin response “when needed”
- Hypoglycemia can occur, especially with insulin or certain diabetes medicines
- Shifts toward greater fat utilization
- Improves muscular energy use
- May reduce low-grade inflammation
- May modestly lower blood pressure
- Vascular benefits cannot be assumed for every patient
- Cardiac outcomes depend on the condition and trial population
- Effects on edema are not established for this treatment
- Potential bone and cognitive benefits are being studied
- Overall support for healthy routines
- It assists your own physiology—no “magic bullet”
- Benefits may build over weeks to months
- Balanced diet + gentle activity improve outcomes
Weight-loss effectiveness
In SURMOUNT-1, adults with obesity or overweight and a weight-related complication, without diabetes, received lifestyle support. At 72 weeks, mean weight loss was 20.9% with tirzepatide 15 mg versus 3.1% with placebo. These are trial averages, not a prediction for an individual or a starting dose.
Targets appetite, satiety, and glycemia—favoring steady change over harsh restriction.
Response varies with dose and habits. If nausea occurs, physicians can pause/escalate more gradually.
Regular meals, adequate protein, and light activity further improve composition and metabolic markers.
Reference: Jastreboff AM, et al. N Engl J Med. 2022;387(3):205–216.
Results are population averages; individual responses vary.
Recommended for
Helps reduce urges for snacking or late-evening overeating.
Fully online; nationwide delivery supports continuity.
Titrate at a comfortable pace with medical guidance.
Complements diet and activity to push past stalls.
Process to online prescription
Book a phone consultation and check available appointments online. Delivery is available within Japan.
How to use (follow your doctor’s instructions)
Self-inject once per week on the same weekday. Typically start at 2.5 mg.
Clean the site (abdomen, thigh, or upper arm). Rotate sites each time.
Press the pen vertically and inject as instructed. Keep it pressed for a few seconds after the signal.
Watch for nausea, vomiting, diarrhea/constipation, or abdominal pain. If severe symptoms occur, stop and seek care.
Medical information checked: 12 October 2026. Japanese prescribing information (PMDA). Follow the prescription and instructions for your exact product.
Pricing
Your total = medicine price + applicable handling fee. Prices include tax. Consultation with a medicine purchase is ¥0. Standard refrigerated shipping is currently ¥0 (the usual cool-courier charge is ¥2,000).
When ordering only one Mounjaro pen, add ¥2,000 handling. This fee is waived if another medicine is included in the same order; that medicine is charged separately. Orders of 2 or more pens have no single-pen handling fee.
Completed consultation without a purchase / prescription declined: ¥3,000 consultation fee. If questionnaire assessment results in no consultation being performed: ¥0 consultation fee.
Weight-loss Simulator
Visualize your path to a target weight, factoring Mounjaro use and lifestyle improvements (for reference only).
Mounjaro Weight-loss Simulator
Estimate your journey in about 3 minutes
Projected timeline
Combination therapy (when appropriate)
Your physician may suggest add-ons based on your profile. Examples that can be synergistic:
Aim: Increase urinary glucose excretion to lower net calories.
Best for: Frequent snacks / limited time to exercise.
Aim: Temper appetite impulses.
Best for: Evening overeating / compulsive snacking.
Aim: Reduce hepatic gluconeogenesis and improve insulin resistance.
Best for: Higher fasting glucose / weight-neutral preference.
Aim: Support bowel movements and fluid balance—useful for subcutaneous-fat type edema/constipation.
Best for: Constipation / edema / diet reset.
FAQ
Can I get Mounjaro via online consultation?
Notes:
• Under 18: parental consent is required.
• Existing conditions: please inform us during the teleconsultation.
How much does it cost? Is it covered by insurance?
• 2.5 mg: 6,000 JPY per pen (24,000 JPY / 4 pens)
• 5.0 mg: 9,500 JPY per pen (38,000 JPY / 4 pens)
• 7.5 mg: 12,000 JPY per pen (48,000 JPY / 4 pens)
• 10 mg: 15,000 JPY per pen (60,000 JPY / 4 pens)
• 12.5 mg: 19,000 JPY per pen (76,000 JPY / 4 pens)
• 15 mg: 23,000 JPY per pen (92,000 JPY / 4 pens)
A ¥2,000 handling fee applies to one pen alone; it is waived when another medicine is included in the same order. A completed consultation without a medicine purchase costs ¥3,000. No consultation fee is charged if questionnaire review results in no consultation. Refrigerated shipping is currently free. Payments: credit card (VISA/Mastercard/JCB/AMEX) or bank transfer.
When will it arrive?
When might I feel an effect?
Any diet or exercise precautions while on Mounjaro?
What if I experience side effects?
Will I regain weight after stopping?
Can I self-inject if I’m needle-averse?
Can I take it with other medicines or supplements?
Is an online prescription safe?
How should I store it?
Where can I find the expiration date?
Can I inject immediately after taking it out of the fridge?
Can I purchase it like online shopping?
Where can I ask questions?
Do I need a Japanese address or residence card?
Can I use a foreign credit card?
Can you ship to my hotel or Airbnb?
Can I consult before arriving in Japan?
I do not have a Japanese phone number. How can I have the consultation?
Can my family or friend in Japan receive the delivery on my behalf?
Can I get an English Doctor Letter for customs?
About the medicine used at our clinic (Mounjaro)
In Japan, Mounjaro is approved for type 2 diabetes. Its use for weight management is off-label; Zepbound is a separate tirzepatide product with an obesity indication under specific conditions.
We procure via authorized pharmaceutical distributors and manage products appropriately.
Examples include Sanorex (anorectic) and Wegovy (semaglutide). Tirzepatide (Zepbound) received domestic obesity approval in Dec 2024.
Tirzepatide is approved for obesity in the US (FDA) and in Japan (Dec 27, 2024). Possible adverse events include acute pancreatitis, hypoglycemia, nausea, vomiting, abdominal pain, diarrhea, and constipation. Seek medical help if you feel unwell.
Because weight-management use is private/off-label, Japan’s governmental adverse-event relief schemes do not apply.
